IODIPAMIDE MEGLUMINE: 38 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
38
Total FAERS Reports
37 (97.4%)
Deaths Reported
38
Hospitalizations
38
As Primary/Secondary Suspect
37
Life-Threatening
37
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
FDA Application: 009321 ·
First Report: 20100517 · Latest Report: 20150818
What Are the Most Common IODIPAMIDE MEGLUMINE Side Effects?
#1 Most Reported
Off label use
34 reports (89.5%)
#2 Most Reported
Hypercholesterolaemia
31 reports (81.6%)
#3 Most Reported
Duodenal ulcer perforation
31 reports (81.6%)
All IODIPAMIDE MEGLUMINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 34 | 89.5% | 34 | 34 |
| Duodenal ulcer perforation | 31 | 81.6% | 31 | 31 |
| Hypercholesterolaemia | 31 | 81.6% | 31 | 31 |
| Blepharospasm | 30 | 79.0% | 30 | 30 |
| Depression | 30 | 79.0% | 30 | 30 |
| Epilepsy | 30 | 79.0% | 30 | 30 |
| Fibromyalgia | 30 | 79.0% | 30 | 30 |
| Helicobacter infection | 30 | 79.0% | 30 | 30 |
| Breast cancer stage iii | 29 | 76.3% | 29 | 29 |
| Dry mouth | 29 | 76.3% | 29 | 29 |
| Abdominal pain upper | 28 | 73.7% | 28 | 28 |
| Asthenia | 28 | 73.7% | 28 | 28 |
| Diarrhoea | 28 | 73.7% | 28 | 28 |
| Facet joint syndrome | 28 | 73.7% | 28 | 28 |
| Blister | 27 | 71.1% | 27 | 27 |
| Dizziness | 27 | 71.1% | 27 | 27 |
| Vomiting | 27 | 71.1% | 27 | 27 |
| Hypertension | 25 | 65.8% | 25 | 25 |
| Back injury | 24 | 63.2% | 24 | 24 |
| Hypersensitivity | 23 | 60.5% | 23 | 23 |
Who Reports IODIPAMIDE MEGLUMINE Side Effects? Age & Gender Data
Gender: 98.0% female, 2.0% male. Average age: 40.5 years. Most reports from: CA. View detailed demographics →
Is IODIPAMIDE MEGLUMINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 1 | 0 | 1 |
| 2015 | 3 | 3 | 3 |
What Is IODIPAMIDE MEGLUMINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 33 |
Official FDA Label for IODIPAMIDE MEGLUMINE
Official prescribing information from the FDA-approved drug label.